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CD2AP Links Cortactin and Capping Protein at the Cell Periphery To
Facilitate Formation of Lamellipodia
Jianping Zhao,a Serawit Bruck,a* Saso Cemerski,a Lei Zhang,a Boyd Butler,b Adish Dani,a John A. Cooper,b Andrey S. Shawa,c
Department of Pathology and Immunology,a Department of Cell Biology and Physiology,b and Howard Hughes Medical Institute,c Washington University School of
Medicine, St. Louis, Missouri, USA
Understanding the physiology of complex relationships between components of signaling pathways and the actin cytoskel-
eton is an important challenge. CD2AP is a membrane scaffold protein implicated in a variety of physiological and disease
processes. The physiological function of CD2AP is unclear, but its biochemical interactions suggest that it has a role in dy-
namic actin assembly. Here, we report that CD2AP functions to facilitate the recruitment of actin capping protein (CP) to
the Src kinase substrate, cortactin, at the cell periphery, and that this is necessary for formation of the short branched fila-
ments that characterize lamellipodium formation and are required for cell migration. Superresolution fluorescence mi-
croscopy demonstrated that the efficient colocalization of CP and cortactin at the cell periphery required CD2AP. As both
cortactin and CP function to enhance branched actin filament formation, CD2AP functions synergistically to enhance the
function of both proteins. Our data demonstrate how the interplay between specialized actin regulatory molecules shapes
the actin cytoskeleton.
Animal cells control their shape and move about by regulatingthe assembly of actin filaments in space and time. Unique cell
shapes and movements are defining features of differentiated cell
function, and they change in the course of pathological processes.
While a number of molecular components capable of interacting
with actin and controlling its polymerization have been identified,
the field has a very limited understanding of how this complex
array of components, with a multitude of biochemical interac-
tions, works together to assemble actin and produce the forces
that dictate shape and power movement.
Using biochemical approaches, we identified several actin reg-
ulatory proteins as interacting with the membrane scaffold
CD2AP (1). However, the physiological significance of these in-
teractions is not known. Here, we address this question with ex-
periments that reveal that interactions of CD2AP with CP and
cortactin indeed have physiological significance, and we elucidate
how these interactions lead to spatial and temporal recruitment
and assembly of the actin filament network that drives cell shape
changes at the periphery of motile cells.
CD2AP is a signaling scaffold protein originally discovered to
be necessary for the formation of the actin-based immunological
synapse (2). CD2AP is expressed in a wide variety of cells, with
higher levels in epithelial cells, immune cells, and neurons (3).
Loss of CD2AP from glomerular epithelial cells, also known as
podocytes, leads to renal failure (4). Human genetic studies have
also implicated CD2AP in the pathogenesis of Alzheimer’s disease
(5, 6). Several groups, including our own, identified a biochemical
interaction between CD2AP and CP (1, 7). In our previous work,
we found the interaction between CP and CD2AP to be of high
affinity (dissociation constant [Kd], 2.4 nM) (1), and we defined a
CP binding motif in CD2AP which is present in a number of
known CP binding proteins that are otherwise unrelated (8).
Whether CD2AP binding to CP in cells enhances or inhibits the
actin capping activity of CP remains an open question, along with
the possibility that CD2AP recruits CP to the membrane. CD2AP
was also found to associate with the actin regulatory protein cor-
tactin in biochemical studies (9). Cortactin binds to F-actin and
the Arp2/3 complex, and this promotes the formation of branched
networks of actin filaments (10–12). CD2AP interacts with the Src
homology 3 (SH3) domain of cortactin, and epidermal growth
factor induces formation of a CD2AP/cortactin complex in mem-
brane ruffles (9). The physiological significance of this interaction,
however, remains unclear.
Here, we examined, for the first time, the biological role of the
CD2AP-CP interaction. We discovered that CD2AP recruits CP to
the cell periphery, close to the actin filament barbed ends that can
be capped by CP. Loss of CD2AP led to loss of CP recruitment to
the cell periphery, and this depended on the direct interaction
between the two proteins. Furthermore, we discovered that re-
cruitment of CD2AP to the cell periphery was mediated by an
interaction of CD2AP with cortactin. Together, our results suggest
that the formation of lamellipodia is mediated by a complex of
cortactin, CD2AP, and CP. The formation of this complex may
help to create a feedback loop that promotes the formation of a
branching network of actin filaments in lamellipodia.
MATERIALS AND METHODS
DNA constructs, lentivirus, and regents. Green fluorescent protein
(GFP) fused to actin was subcloned into a retroviral expression vector
driven by the pMX promoter (13). CD2AP short interfering RNA
(siRNA) oligonucleotides were designed using Invitrogen BLOCK-iT
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RNA interference (RNAi) design tools. The oligonucleotides were cloned
into the pFLRu lentivirus vector with yellow fluorescent protein (YFP) tag
provided by Greg Longmore (Washington University, St. Louis, MO)
(14). The mutated forms of CD2AP were generated using PCR, cloned
into pEGFP-C1/N1 vectors (Clontech), and confirmed by DNA sequenc-
ing. Mouse cortactin, RNAi-resistant cortactinR, and cortactinR-W525K
(with a defective SH3 domain) (15) were cloned into pFLAG-CMV-6c
(Sigma) or pTurboRFP-C vector (Evrogen). pFLRu-CD2AP-CT lentivi-
rus vector was made by replacing YFP with GFP-CD2AP-CT (C-terminal
half of CD2AP) in the pFLRu vector, and small hairpin RNAs (shRNAs)
against cortactin (15) or luciferase were cloned into pFLRu-CD2AP-CT.
Anti-CD2AP rabbit polyclonal antibody (Ab) was prepared in the labora-
tory. Anticortactin (MAb 4F11) was purchased from Millipore. Anti-
FLAG (monoclonal Ab [MAb] M2) and agarose beads conjugated with
anti-FLAG were from Sigma. Anti-GFP (MAb JL-8) was from Clontech,
and anti-GFP (chicken IgY) was from Invitrogen.
Cell culture and transfection. Immortalized mouse podocytes de-
rived from wild-type or CD2AP-deficient mice were cultured at 33°C in
RPMI 1640 supplemented with antibiotics, 10% fetal calf serum, and
gamma interferon (IFN-) (16). 293T cells were cultured in Dulbecco’s
modified Eagle medium (DMEM) supplemented with antibiotics and
10% fetal calf serum. Enhanced GFP (EGFP) fused to actin in a retroviral
vector was transfected into Plat-E packaging cells (17). The virus secreted
by these cells was used to infect the podocytes. Cells stably expressing low
levels of GFP-actin were used for fluorescence recovery after photobleach-
ing (FRAP) experiments, and a total internal reflection fluorescence
(TIRF) microscope was used. CD2AP or cortactin RNAi lentivirus was
used to infect podocytes, and RNAi efficiency was evaluated by Western
blotting. Wild-type and CD2AP-deficient podocytes were transiently
transfected with plasmids using Amaxa nucleofection (Lonza) or Lipo-
fectamine 2000 (Invitrogen).
Cell motility, cell spreading, and video microscopy. Podocytes were
grown in 60-mm tissue culture dishes to confluence, and a scratch wound
was created with a pipette tip. Cells were allowed to recover for 30 min
before imaging migration over a 24-h time period using bright-field optics
on an upright microscope with a 10 objective. For video microscopy, a
Cascade charge-coupled device (CCD) camera was used. Video was com-
piled using Metamorph software (Universal Imaging Corp). Alterna-
tively, cells were stained with DRAQ5 (Alexis Biochemicals, Lausen, Swit-
zerland) at time zero, and then, 17.5 h postscratch, they were fixed and
imaged using a Zeiss LSM510 confocal microscope with a 10 objective.
The number of cells that migrated toward the wound was counted for each
cell type. Cell spreading was performed by replating trypsinized cells in
Ringers lactate (5 mM HEPES, pH 7.2 to 7.4, 155 mM NaCl, 3 mM HCl, 2
mM CaCl2, 1 mM MgCl2, 3 mM NaH2PO4, 10 mM glucose) onto acid-
washed coverslips. Cells were allowed to attach for 5 min and spread for 5
or 15 min. They were then fixed and imaged by phase-contrast micros-
copy.
TIRF microscopy. To image by TIRF the actin dynamics of spreading
wild-type and CD2AP-deficient podocytes, we dropped trypsinized cells sta-
bly expressing GFP-actin on collagen-coated glass-bottom culture dishes
(MatTek Corporation, Ashland, MA). The TIRF microscopy system
(through the lens) included an inverted microscope (IX-81; Olympus Amer-
ica, Center Valley, PA) and an electron multiplication back-thinned frame
transfer CCD video camera (model C9100-12; Hamamatsu Photonics,
Bridgewater, NJ) with a 60, 1.45-numerical-aperture (NA) PlanApo oil
objective. SlideBook software (Intelligent Imaging Innovations, Denver, CO)
operated the system and collected the images. Frames were collected every 3 s
for 7 min.
Confocal microscopy, FRAP, and lamellipodium localization quan-
tification. Cells were grown on acid-washed, 2.5-cm coverslips or glass
dishes for 16 h before imaging. All live-cell imaging was performed at 37°C
using a directly heated coverslip system (Bioptechs, Scranton, PA). Scan-
ning confocal microscopy was performed on a Zeiss LSM 510 with a 40,
1.2-NA water objective or Olympus FluoView FV1000. For the dynamics
of actin in the cytoplasm or plasma membrane, GFP was bleached with
100% of an 8-mW, 488-nm laser applied to a 4- by 0.5-m rectangle. This
region was bleached for 5 s, and then the same region was imaged at less
than 5% of the bleach power. The images were acquired at 200-ms inter-
vals. The intensity of GFP-actin before bleaching was set at 1, and the
bleaching was set at 0. The ratio of the recovered to the original intensity
was plotted against time (in seconds) using Microsoft Excel. The intensity
of the bleached area was corrected for photobleaching. The nonlinear fit
analysis was conducted using PRISM5 software (Graphpad). To quantify
lamellipodium localization, cells transfected with GFP-tagged CD2AP
mutants were replated onto a glass coverslip and fixed with 4% parafor-
maldehyde (PFA). Using confocal microscopy, lamellipodia were identi-
fied as thin protrusive sheets of membrane at the periphery of the cell. As
it is sometimes difficult to distinguish between membrane ruffles and
lamellipodia, only cells exhibiting GFP signals in clearly discernible lamel-
lipodia were counted as positive. For each group, averages of 80 to 100
cells were analyzed and quantified.
Immunoprecipitation. 293T cells were cotransfected with FLAG-
cortactin and CD2AP or CD2AP-PR2-GFP. Two days after transfec-
tion, the cells were lysed with phosphate-buffered saline (PBS) con-
taining 1% Triton X-100, 10 mM NaF, 1 mM Na3VO4, 0.2 mM
phenylmethylsulfonyl fluoride (PMSF), 1 M pepstatin, 1 g/ml
aprotinin, and 10 M leupeptin. The cell lysates (500 g) were incu-
bated with agarose beads conjugated with anti-FLAG MAb M2
(Sigma) at 4°C for 4 h. The beads were washed 5 times with 1% Triton
X-100 in PBS, and immunoprecipitates were analyzed by immuno-
blotting with anti-GFP and anti-FLAG Abs.
STORM imaging. The stochastic optical reconstruction microscopy
(STORM) setup and imaging were similar to those described before (18).
Briefly, the STORM microscope was constructed around a Nikon Ti-E
inverted microscope operating in wide-field epifluorescence mode and
using the Nikon Perfect Focus system for focus stabilization. The activa-
tion/imaging lasers (CUBE 405 nm-50, Sapphire 561 nm-150, and Sap-
phire 460 nm-10 from Coherent and Stradus 642 nm-110 from Vortran
Laser) were individually shuttered by a mechanical shutter (Uniblitz
LS3ZM2; Vincent Associates) and an acousto-optical tunable filter
(AOTF; PCAOM; Crystal Technology). Laser lines were combined, ex-
panded, and collimated before being focused at the back focal plane of a
100 objective (100 UPlanSApo; NA, 1.4; Olympus). A quad-band
dichroic mirror (zt405/488/561/640rpc; Chroma) and a band-pass filter
(ET705/70m; Chroma) separated the fluorescence signal collected by the
same objective from the excitation light. Images were recorded with an
electron-multiplying CCD (EMCCD) camera (iXon Plus DU897; Andor).
Podocytes transfected with GFP-CP were plated on coverglass and
stained with anti-CD2AP and anticortactin or anti-CD2AP and anti-GFP.
Secondary antibodies for STORM were custom conjugated with Cy3-
Alexa 647 (A647) and Alexa 405-A647 dye pairs as described before (6).
Antibody control was prepared by adhering a diluted mixture of anti-
mouse Cy3-A647-conjugated and anti-rabbit 405-A647-conjugated sec-
ondary antibodies to a coverglass flow cell. All imagings were performed
by inverting coverslips onto a glass slide with imaging buffer (80:10:10:1
ratio of PBS, 1 M mercaptoethylamine [pH 8.5], 50% glucose solution in
water, and an antibleaching oxygen scavenger system [10 mg of glucose
oxidase plus 25 l of catalase and 100 l of PBS]). Excess buffer was
drained and the edges sealed with nail polish before image acquisition.
Colocalization and cross-correlation analysis. STORM images of en-
tire cells were reconstructed using Gaussian fitting to find the center po-
sition of single molecules. The fitted positions were saved as a binary
image of localization/no localization with a pixilation grid size of 40 nm.
Cross-correlation analysis was performed as described recently (19) on
6-m2 square regions of interest (ROI), using 10 ROIs for each cell and 6
cells for each sample. Cross-correlation functions of the ROI from two
channels were calculated using a custom-written MatLab script using a
fast Fourier transform (FFT). The cross-correlation function represents
the probability of finding a second channel localization at a certain dis-
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tance, r, from the first channel. A value of 1 represents a random distri-
bution between the two channels, and values higher than 1 suggest a
correlation of two channel molecules at a certain distance.
Colocalization analysis was performed using Manders’ overlap coeffi-
cient, which is based on Pearson’s coefficient (20). Briefly, the Manders’
overlap coefficient represents the degree of colocalization between the two
channels. Ten randomly selected 6-m2 ROIs at the cell periphery and in
cytoplasm in 6 separate cells were analyzed for each cell type. Six randomly
selected 6-m2 regions of interest were also analyzed on the antibody
control sample.
RESULTS
CP recruitment to the cell leading edge is impaired in CD2AP-
deficient cells. Since CP is important in the formation of actin-
based structures at the cell periphery (21, 22), our initial experi-
ments examined whether CD2AP plays a role in CP recruitment to
the periphery of spreading podocyte cells. Using both confocal
and TIRF microscopy, we localized CD2AP and CP during the
initial phases of cell spreading. We first confirmed that CD2AP is
efficiently recruited to the cell periphery by expressing a green
fluorescent protein (GFP)/CD2AP fusion protein (CD2AP-GFP).
Wild-type podocytes were allowed to adhere to glass and spread
for up to 30 min. Confocal microscopy showed that CD2AP was
recruited to the cell periphery in 56% of cells (Fig. 1A), and TIRF
microscopy showed that it was evenly distributed on the adherent
surface of the cell during the process of cell spreading (Fig. 1B).
The recruitment of CP to the periphery of wild-type podocytes
was assessed using a GFP-capping protein fusion protein (GFP-
CP). Confocal microscopy showed that it localized mainly in the
cytoplasm and also at the periphery of the cell in a smooth and
even pattern in 43% of cells (Fig. 1C). TIRF microscopy showed
that CP was recruited to the entire adherent surface of the cell
(Fig. 1D).
To determine whether CP recruitment to the periphery was
defective in CD2AP-deficient cells, we expressed GFP-CP in
CD2AP-deficient podocytes and imaged its localization during
spreading. In contrast to the wild-type cells, CP recruitment to the
periphery was extremely irregular and patchy in CD2AP-deficient
cells (Fig. 1E). This pattern was observed at early time points; at
later time points (60 min), the pattern resembled that seen in
wild-type cells (data not shown). Thus, efficient recruitment of CP
to the cell periphery at early time points during cell spreading
might be mediated by CD2AP.
To confirm that the CP recruitment defect was due to the fail-
ure of CP to interact with CD2AP, we tested the function of a
CD2AP mutant defective in binding CP. Expression of wild-type
CD2AP in CD2AP-deficient podocytes largely rescued CP recruit-
ment relative to the recruitment in the CD2AP-knockout cells as
assessed by confocal and TIRF microscopy (Fig. 1F). Expression of
a mutated form of CD2AP (474-513), which lacks the CP bind-
ing site (1), was unable to rescue the peripheral recruitment of CP,
and the cells were largely indistinguishable from CD2AP-deficient
cells (Fig. 1G). Lastly, since Arg 493 and Lys 495 of CD2AP are
both critical for the CP interaction, we generated a mutated form
of CD2AP substituting alanine for both of these residues. As ex-
pected, the R493A/K495A mutant also failed to rescue the CP
recruitment and spreading phenotype (data not shown). Thus,
CD2AP facilitates the recruitment of CP to the periphery of
spreading cells, apparently through a direct molecular interaction.
CD2AP influences the actin-based morphology of cell edges
during podocyte spreading. Since CP is important in the forma-
tion of actin-based structures during cell spreading, we assessed
the morphology of CD2AP-deficient cells during cell spreading by
phase-contrast microscopy (Fig. 2A and B). As illustrated in Fig.
2A, we scored the morphology of spreading cells into three cate-
gories, smooth edged, filopodial, and ruffling, using a classifica-
tion scheme developed by Borisy and coworkers (23). Wild-type
cells generally exhibited either a circular spreading pattern with a
flat, smooth edge (35% at 5 min, 60% at 15 min), which we
would describe as lamellar, or they exhibited dynamic phase-
dense, thick undulations, which were scored as ruffling (45% at
5 min, 35% at 15 min) (Fig. 2B). CD2AP-deficient cells spread in
an asymmetric pattern with an increased number of cells exhibit-
ing dynamic finger-like projections of the cell edge (20% at 5
min, 15% at 15 min), a pattern which we scored as filopodial with
an increased number of cells exhibiting the ruffling appearance
(70% at 5 min, 80% at 15 min) (Fig. 2B). Thus, cell spreading is
affected by the loss of CD2AP, with changes in the morphology of
the actin-based structures at the spreading edge of the cells. Inter-
estingly, the observed increase in ruffling and filopodial patterns is
similar to the effects described for the loss of CP (21, 22).
To examine the actin cytoskeleton during cell spreading, we
expressed GFP-actin in the cells and used TIRF video microscopy.
While wild-type cells exhibited a smooth and circumferential dis-
tribution of actin during spreading, the CD2AP-deficient cells ex-
FIG 1 CD2AP facilitates CP recruitment to the cell periphery. Shown are a
confocal image (A) and TIRF image (B) of a wild-type (WT) podocyte tran-
siently transfected with CD2AP-GFP spreading on glass. Bar, 10 m. (C and
D) Confocal image (C) and TIRF image (D) of a wild-type podocyte tran-
siently transfected with GFP-CP spreading on glass. (E) Defective CP recruit-
ment to the cell periphery in CD2AP-deficient (KO) podocytes. CD2AP KO
podocytes were transiently transfected with GFP-CP, plated on glass, and im-
aged using TIRF microscopy. Bar, 10 m. (F) Expression of wild-type CD2AP
rescues CP recruitment to the periphery during cell spreading. CD2AP KO
podocytes were transiently cotransfected with wild-type CD2AP and GFP-CP
and imaged using TIRF microscopy. The transfected cells were identified using
immunofluorescence. (G) A mutated form of CD2AP (474-513) unable to
bind to CP cannot rescue the CP recruitment defect. CD2AP-deficient podo-
cytes were transiently cotransfected with CD2AP (474-513) and GFP-CP and
then imaged by TIRF microscopy. We confirmed that the level of expression of
the mutated CD2AP was similar to or higher than that of the wild-type CD2AP
in individual cells by immunofluorescence staining with an antibody to
CD2AP (data not shown).
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hibited a patchy and irregular pattern of actin (see Movies S1 and
S2 in the supplemental material). These results confirm that
CD2AP is important for the structure and dynamics of the actin
cytoskeleton at the edge of the cell during spreading.
CD2AP-deficient podocytes have a motility defect. Altera-
tions in the actin-based protrusive structures at the cell edge might
be expected to have effects on cell migration. We assessed the role
of CD2AP in cell migration using a standard scratch-wound heal-
ing assay. Wild-type or CD2AP-deficient podocytes were plated
on tissue culture dishes (data not shown) or on glass coverslips
(Fig. 2) and allowed to grow to confluence and then differentiated
for 2 weeks. A scratch wound was created on the monolayer using
a pipette tip, and the cells were monitored for 16 to 24 h by video
microscopy. While wild-type cells closed the wound in 14 to 18 h,
loss of CD2AP led to slower migration of cells into the wound
based on measurements of the thickness of the wound (Fig. 2C)
and the number of cells migrated into the wound (Fig. 2D). Video
microscopy also demonstrated that while the wild-type podocytes
moved in a coordinated sheet-like manner, the CD2AP-deficient
podocytes moved more discordantly (see Movies S3 and S4 in the
supplemental material). We confirmed that the phenotype was
specific to CD2AP and not a clone-specific difference by using two
different lentivirus-expressed shRNAs to downregulate CD2AP
expression in wild-type cells (data not shown). The shRNA-
treated cells behaved similarly to the CD2AP-deficient podocytes,
suggesting that the CP recruitment defect mediated by CD2AP
also affects cell motility.
CD2AP affects the dynamics of actin at the periphery of the
cell. If CD2AP is facilitating CP recruitment to the cell periphery,
it might be expected that actin dynamics in the absence of CD2AP
would be affected at the cell periphery. We addressed this question
using FRAP to measure the turnover of actin filaments in wild-
type and CD2AP-deficient podocyte cells stably transfected with
GFP-actin. We bleached an area at the periphery of the cell and
monitored the fluorescence recovery over the following 60 s (Fig.
3A). In wild-type cells, the mobile fraction was 22%, and the half-
time for recovery was 18.1  0.8 s (n 	 49) (Fig. 3B). In CD2AP-
FIG 2 CD2AP is required for efficient cell spreading and migration. (A) Wild-
type and CD2AP-deficient podocytes were plated onto glass coverslips and
fixed after 5 or 15 min. Cells were classified into three different morphologies,
examples of which are shown in Fig. 1. The smooth-edge phenotype is char-
acterized by a flat, evenly spreading leading edge. The ruffling phenotype is
characterized by phase-dense undulations of the peripheral membrane. The
filopodial phenotype is characterized by finger-like protrusions at the periph-
ery of the cell. (B) Quantification of the smooth-edge, ruffling, and filopodial
phenotypes of wild-type and CD2AP-deficient podocytes. Phenotypes were
assessed by phase-contrast microscopy of fixed podocytes at 5 and 15 min after
making contact with a glass slide. Images were scored blinded and classified as
one of the three phenotypes. Most of the wild-type podocytes displayed
smooth-edge and ruffling phenotypes. In contrast, the CD2AP-deficient
podocytes had a higher propensity to spread with ruffling phenotype. (C)
Wound healing assay. Wild-type (WT) and CD2AP-deficient (KO) podocytes
were grown to confluence. A wound was inflicted with a p200 pipette tip. At
17.5 h later, the cells were fixed and stained with DRAQ5 and imaged using
confocal microscopy. The white lines represent the boundaries of the original
wound. (D) Column bar graph showing the number of cells that migrated
toward the wound. A box was drawn at the boundaries of the original wound,
and cells within the box after 17.5 h were counted. Fewer CD2AP-deficient
podocytes than wild-type cells had migrated into the wound.
FIG 3 CD2AP affects actin dynamics at the cell periphery. Actin dynamics
were measured by FRAP in wild-type (WT) and CD2AP-deficient (KO) podo-
cytes stably expressing GFP-actin. (A) A 2-m2 area adjacent to the plasma
membrane was bleached, and fluorescence recovery was measured over 60 s.
The recovery of actin in wild-type cells (n 	 48) was higher and faster than the
recovery of CD2AP-deficient cells (n 	 49). (B) Nonlinear fit analysis using
PRISM5 of FRAP experiments of the periphery of CD2AP WT and CD2AP-
deficient podocytes using the average of multiple cells as described for panel A.
The half-life of actin recovery in wild-type podocytes is 18.1  0.8 s, and the
half-life of actin recovery in CD2AP-deficient podocytes is 39.1  5.5 s. (C) A
2-m2 area in the cytoplasm adjacent to the nucleus was bleached, and fluo-
rescence recovery was measured over 30 s. Both wild-type (n 	 6) and CD2AP-
deficient cells (n 	 16) showed similar rates of recovery.
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deficient cells, the mobile fraction was 16%, and the half-time for
recovery was 39.1  5.5 s (n 	 49). We also bleached an area in the
center of the cell near the nucleus. Here, we saw no difference
between wild-type and CD2AP-deficient cells in terms of mobile
fraction or recovery time (Fig. 3C). Thus, CD2AP promotes the
dynamic turnover of actin filaments at the periphery of the cell,
consistent with a role in actin assembly and actin-based motility.
Localization of CD2AP to the cell periphery requires its C
terminus and binding to cortactin. To investigate the mechanism
of how CD2AP is recruited to the periphery of the cell, we analyzed
the localization of various deletion mutants of CD2AP. CD2AP
contains several potential protein interaction domains, including
three Src homology 3 (SH3) domains at the amino terminus, a
proline-rich region, and a coiled-coil domain at the carboxy-ter-
minal half. We first tested a construct consisting of the N-terminal
half of CD2AP, including the three SH3 domains (CD2AP-NT),
and a second construct consisting of the C-terminal half of
CD2AP, including the proline-rich sequences and the coiled-coil
domain (CD2AP-CT). Both were fused to GFP. While the C-ter-
minal half of CD2AP localized to the cell periphery in 51% of
cells in a pattern similar to that of full-length CD2AP (43%), the
construct containing the N-terminal half of CD2AP rarely local-
ized to the periphery (5%) (Fig. 4A to C). Thus, the C-terminal
half of CD2AP is necessary and sufficient for its localization to the
cell periphery.
It was previously reported that cortactin can interact with the
C-terminal half of CD2AP (9), but the function of this interaction
was not determined. Cortactin binds to the Arp2/3 complex and
actin filaments and promotes Arp2/3 complex-mediated actin po-
lymerization (11, 12, 24, 25). Cortactin is also important for the
assembly of actin-based structures that contribute to cell migra-
tion (26). We therefore considered whether cortactin mediates the
recruitment of CD2AP to the periphery. We first examined the
localization of cortactin in wild-type and CD2AP-deficient podo-
cytes. In cells expressing a red fluorescent protein (RFP)-tagged
form of cortactin, RFP-cortactin localization was not affected by
the loss of CD2AP (Fig. 5A and B), suggesting that cortactin local-
ization does not depend on CD2AP. Furthermore, coexpressing
RFP-cortactin and GFP-CD2AP-CT showed that they colocalized
in the periphery of CD2AP-deficient podocytes (Fig. 5C to E).
To determine whether a direct interaction between cortactin
and CD2AP is important for localization of CD2AP, we generated
a CD2AP mutant unable to bind cortactin. Cortactin binds to the
second of three proline-rich sequences (PR2) in CD2AP (9). We
therefore generated a CD2AP mutant lacking only the second pro-
line-rich sequence (CD2AP-PR2-GFP), and we confirmed that
this mutant is unable to bind cortactin by coimmunoprecipitation
(Fig. 5F). Localization studies showed that this mutant localized
poorly to the cell periphery (8%), suggesting that direct binding
to cortactin is the mechanism for the peripheral localization of
CD2AP (Fig. 5G).
To prove this, we used lentiviruses that coexpressed shRNAs
targeting cortactin and GFP-CD2AP-CT (Fig. 6A and B). While
GFP-CD2AP-CT localized to the periphery in 56% of podocytes
infected with the control shRNA lentivirus (Fig. 6C), CD2AP lo-
FIG 4 Lamellipodial localization of CD2AP requires its C-terminal domain.
(A to C) CD2AP KO podocytes were transfected with cDNAs encoding GFP-
tagged full-length CD2AP (GFP-CD2AP), the GFP-tagged N-terminal half of
CD2AP (CD2AP-NT), or the GFP-tagged C-terminal half of CD2AP (CD2AP-
CT). Twenty-four hours after transfection, cells were replated on glass-bottom
dishes and images were acquired using confocal microscopy. Bar, 10 m. (D)
Schematic depiction of GFP-CD2AP constructs. Pro, proline-rich sequence;
CC, coiled-coil sequence. The asterisk indicates the binding site for CP. (E)
Immunoblotting of CD2AP KO podocytes expressing various GFP-tagged
CD2AP constructs. FIG 5 Interaction of CD2AP with cortactin is required for lamellipodial
localization. (A and B) Cortactin localization is unaffected by the absence
of CD2AP. RFP-cortactin was transfected into wild-type (WT) podocytes
(A) or CD2AP-deficient (KO) podocytes (B). Twenty-four hours after
transfection, cells were replated and images were acquired using confocal
microscopy. Bar, 10 m. (C to E) Colocalization of CD2AP-CT and cor-
tactin by immunofluorescence microscopy. CD2AP KO podocytes were
cotransfected with GFP-CD2AP-CT and RFP-cortactin and imaged as de-
scribed above. Bar, 10 m. In the overlay image, CD2AP is green and
cortactin is red. (F) CD2AP PR2 mutant does not bind to cortactin. 293T
cells were cotransfected with FLAG-cortactin and either the wild type or
the PR2 mutant of CD2AP. Cell lysates were prepared and anti-FLAG
immunoprecipitates (IP) were immunoblotted with antibodies to FLAG
(bottom row) or GFP (top and middle rows). (G) Recruitment of CD2AP
to lamellipodia requires the PR2 domain of CD2AP. KO podocytes were
transfected with GFP-tagged CD2AP-PR2 and imaged as described
above. No significant membrane localization was seen.
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calization to the periphery was significantly impaired in CD2AP-
deficient podocytes infected with either of two different cortactin
shRNA lentiviruses (11%) (Fig. 6D and E). Since the SH3 do-
main of cortactin binds directly to CD2AP (9), we next tested
whether a cortactin SH3 mutant could rescue the localization of
CD2AP. CD2AP-deficient podocytes stably transduced with lentivi-
ruses coexpressing an shRNA against cortactin and GFP-CD2AP-CT
were subsequently transfected with plasmids encoding shRNA-resis-
tant forms of either wild-type cortactin (RFP-cortactinR) or an SH3-
mutated form of cortactin (W525K-RFP-cortactinR) (15). While
wild-type cortactin rescued the peripheral localization of CD2AP
(41%) (Fig. 6F to H), the SH3 mutant could not (9%) (Fig. 6I to
K). Thus, CD2AP recruitment to the cell periphery requires the SH3
domain of cortactin as well as the second proline-rich motif of
CD2AP, most likely via a direct interaction of those regions of the
proteins.
To confirm whether cortactin and CP binding to CD2AP was
required for lamellipodial function during cell spreading, we re-
constituted CD2AP-deficient cells with the cortactin binding mu-
tant (PR2) and the CP binding mutant (474-513) of CD2AP
and assessed the morphology of spreading. While the spreading
defect was partially rescued by wild-type CD2AP, neither of the
two CD2AP mutants, PR2 and 474-513, were able to rescue the
lamellipodial defect (Fig. 6B). These results demonstrate that in-
teractions with both cortactin and CP are necessary for CD2AP
function at the cell periphery during spreading.
CD2AP facilitates cortactin/CP complexes in lamellipodia.
Since lamellipodia contain a wide variety of actin-associated pro-
teins (27–29), traditional immunofluorescence colocalization ap-
proaches cannot definitively address whether CD2AP/cortac-
tin/CP complexes are present in the cell periphery. We therefore
used superresolution fluorescence imaging to determine whether
we could detect these complexes at the cell periphery. Superreso-
lution imaging allows for subdiffraction-limit imaging of cellular
macromolecular complexes (30–32). We used a stochastic optical
reconstruction microscopy (STORM)/photoactivable localiza-
tion microscopy (PALM) approach, which achieves nanometer-
scale resolution of individual molecules inside the cell by repeat-
edly imaging a sparse subset of single molecules and using
photoswitchable probes (18). We hypothesized that if CD2AP
functions to link cortactin with CP, the colocalization between the
molecules would be higher in the wild type (Fig. 7A and B) than in
cells deficient in CD2AP (Fig. 7C and D).
Two-color STORM was used to correlate the positions of cor-
tactin and GFP-CP at the cell periphery in cells (Fig. 7A to D).
Since signaling induces CD2AP/cortactin complexes (33), we rea-
soned that complexes should be enriched at the periphery of the
cell compared to the center of the cell. Cortactin/CP colocalization
was quantitated using the Manders’ colocalization coefficient
(Fig. 7E) as well as a pair-correlation algorithm (Fig. 7F) that
determines the probability that a second molecule is found within
a defined distance from the reference molecule. Both analyses
showed that at the cell periphery there was significantly greater
colocalization of GFP-CP with cortactin in wild-type (Fig. 7A)
compared to CD2AP-deficient cells. In addition, coclustering of
CP with cortactin was much lower in the center of the cell. In
separate experiments, STORM imaging confirmed that CD2AP
colocalizes with CP and cortactin at the periphery of wild-type
cells (data not shown). Interestingly, the density of cortactin re-
cruitment was higher in wild-type cells than in CD2AP-deficient
cells (Fig. 7A and B versus C and D), suggesting that CD2AP/CP
recruitment also functions to further enhance cortactin recruit-
ment (data not shown). This supports our model that CD2AP
physically and functionally links CP and cortactin during lamelli-
podium formation.
DISCUSSION
Previously, we showed that CD2AP interacts with CP (1). Since
CP is involved in actin assembly at the plasma membrane (34, 35),
we asked here whether CD2AP affected actin assembly and dy-
namics at the plasma membrane. Supporting an important role
for CD2AP in CP function, we found that the recruitment of CP to
FIG 6 SH3 domain of cortactin is required for CD2AP localization to lamel-
lipodia. (A) Efficient knockdown of cortactin expression using two different
shRNA constructs. CD2AP-deficient (KO) podocytes were transduced with
lentiviruses coexpressing GFP-CD2AP-CT and a control shRNA (luciferase)
or two different cortactin shRNAs (shRNA#1 and shRNA#2). Cell lysates were
prepared and immunoblotted with antibodies to cortactin, GFP, or ERK2. (B)
CP or cortactin binding mutants of CD2AP are unable to reconstitute the
wild-type spreading phenotype. Cell spreading assays of wild-type (WT)
podocytes transfected with GFP alone, GFP-WT-CD2AP, or two CD2AP mu-
tants, PR2 and 474-513, were evaluated for the spreading morphology after
spreading for 15 min. The percentage of cells with the smooth-edge phenotype
is shown. (C to E) Recruitment of CD2AP to lamellipodia requires cortactin
expression. CD2AP KO podocytes infected with lentiviruses expressing GFP-
CD2AP-CT and control or cortactin shRNAs were imaged as described above.
Bar, 10 m. (F to K) Recruitment of CD2AP to lamellipodia requires the SH3
domain of cortactin. A stable cell line from CD2AP-deficient podocytes was
generated through transduction with lentiviruses coexpressing an shRNA
against cortactin and GFP-CD2AP-CT. The cell lines were transiently trans-
fected with shRNA-resistant forms of either wild-type cortactin (RFP-cortact-
inR) or an SH3 mutated form of cortactin (W525K-RFP-cortactinR) and were
imaged as described above.
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the cell periphery was defective in CD2AP-deficient cells, and this
correlated with defects in cell spreading and cell motility. This
effect was specific for the CD2AP-CP interaction, in that express-
ing a mutated form of CD2AP unable to bind to CP in CD2AP-
deficient cells did not rescue the phenotypes. Thus, one important
function of CD2AP appears to be the recruitment of CP to the cell
periphery.
CP plays a critical role in the ability of cells to form the highly
branched actin filament network characteristic of lamellipodia;
inhibition of CP at barbed ends, for example, by proteins such as
formins and Ena/VASP proteins (23, 36, 37) prevents lamellipo-
dium formation, resulting instead in the assembly of the straight
unbranched filaments that support the formation of filopodia
(21). By binding to the fast-growing barbed ends at the periphery
of the cell, CP is thought to promote the production of short actin
filaments and encourage the formation of new branched filaments
nucleated by the Arp2/3 complex (12, 34, 38). The switch between
filopodia and lamellipodia has been proposed to depend on the
local activity of CP (21).
Because of the ability of CP to stop growth at the fast-growing
barbed end of actin filaments, CP was originally considered a neg-
ative regulator of actin polymerization (35, 39). Indeed, acute in-
hibition of CP in a small region of the cell leads to a local increase
in actin polymerization. However, greater complexity was re-
vealed in other studies. First, analysis of actin assembly and mo-
tility in a synthetic Arp2/3 complex-based system revealed that
actin-based motility depended on CP concentration in a complex
manner, with a bell-shaped curve for motility versus CP concen-
tration. High and low CP concentrations did not support Arp2/3
complex-mediated actin assembly and motility as well as an opti-
mal middle concentration did (40). Second, long-term knock-
down of CP in cultured cells resulted in decreased lamellipodia,
which appeared to result from decreased Arp2/3 complex-medi-
ated actin polymerization (21). One potential molecular explana-
tion for this result is that the level of CP controls the length of actin
filament branches in the network and that networks require opti-
mal branch lengths in order to support the force produced by
growing actin filament ends as they push outward on the plasma
membrane.
One outstanding question is to what extent CD2AP inhibits the
actin capping activity of CP. We previously showed that CD2AP
can inhibit the actin capping activity of CP, but the effect is partial
and not complete (1). Consistent with this, structural studies
demonstrate that the CP-binding motif found in CD2AP binds at
a site distinct from the actin-binding surface (1, 8), suggesting that
CP bound to CD2AP still retains actin capping activity. For these
reasons, we speculate that the CP that is targeted to the cell periph-
ery by CD2AP is not inhibited and caps barbed ends.
CD2AP has a particularly critical role in the podocyte, as re-
vealed by the significant kidney phenotype that develops in the
CD2AP-knockout mouse (4). CD2AP has an ortholog, CIN85,
that retains the CP binding site and may be able to function in
place of CD2AP (41). Podocytes, however, express CD2AP but
not CIN85 (41), so the absence of both proteins may be required
to produce the phenotypes seen here. Indeed, the migration and
the spreading defects that we observed were not apparent in
CD2AP-deficient mouse embryonic fibroblasts that express
CIN85 (data not shown). Because the ability of podocytes to
FIG 7 Cortactin and CP complexes at the lamellipodia are facilitated by CD2AP. (A to D) Two-color STORM images of GFP-CP (green) and cortactin (red) were
acquired as described in Materials and Methods for wild-type (WT) (A and B) and CD2AP knockout (KO) (C and D) podocytes. Bar, 5 m. (B and D) A region
of the lamellipodia, boxed in panels A and C, is shown at a resolution high enough to allow the position of individual proteins to be determined and the correlation
analysis to be performed. Bar, 200 nm. (E) Efficient colocalization of CP with cortactin requires CD2AP. Colocalization analysis of CP and cortactin at the cell
periphery in wild-type versus CD2AP knockout cells (left bars) compared to a random position in the cytoplasm (right bars) was first normalized to the density
of cortactin and then analyzed using the Manders’ overlap coefficient. Analysis was performed on 6 randomly selected cells and 10 regions in each cell. Error bars
represent standard deviations. (F) Cross-correlation analysis of CP and cortactin in wild-type versus CD2AP cells was performed on areas of the cell periphery
compared to the cytoplasm, with two different secondary antibodies as a negative control. Each point represents the probability that a spot in the second channel
is present within a distance of r of the spot in the first channel. Values of 1 (y axis) are indicative of a random distribution, while values greater than 1 indicate
colocalization. Data were acquired and analyzed as described in Materials and Methods.
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spread and cover exposed areas of the glomerular basement mem-
brane may be an important response to kidney injury, the defect in
CP recruitment and lamellipodia formation described here may
explain the kidney failure that develops in the CD2AP-deficient
mice (4).
Our finding that cortactin can recruit CD2AP, which then
recruits CP, provides novel insight into the mechanism of actin
polymerization at the cell periphery. Cortactin was first discov-
ered as a major substrate for the Src tyrosine kinase (42). Cor-
tactin contains an acidic Arp2/3 complex-binding region at the
N terminus, similar to regions in WASP and the SCAR/WAVE
proteins, followed by an F-actin-binding region and an SH3
domain at the C terminus. The SH3 domain is able to bind
proline-rich sequences in a variety of proteins, including
CD2AP, WASP, WIP, Shank2, dynamin 2, and Fgd1 (9, 10,
43–45). By coupling modifiers of actin polymerization via its
SH3 domain, cortactin may function to generate different types
of actin structures in the cell.
Cortactin is known to enhance actin polymerization in lamel-
lipodia through its ability to promote the formation of and stabi-
lize Arp2/3 complex-based branched actin filaments (11, 26).
Cortactin is recruited to lamellipodia via its N-terminal and F-
actin-binding regions, suggesting that the Arp2/3 complex and
actin filaments assembled at the cell periphery during spreading
are responsible for cortactin recruitment (42, 46). Our data show-
ing that cortactin then recruits CD2AP and CP demonstrate how
it uses its SH3 domain of cortactin to specifically enhance and
sustain branched actin fiber assembly in lamellipodia. By recruit-
ing CP, CD2AP may generate a positive-feedback loop, with in-
creased branched actin filaments allowing for the recruitment of
additional cortactin molecules. This could explain the decreased
density of peripheral cortactin in CD2AP-deficient cells (data not
shown). Thus, CD2AP synergizes the capping of fast-growing
barbed ends by CP with the Arp2/3 complex-based branching
activity of cortactin. Supporting this idea is the fact that growth
factor stimulation of lamellipodium formation is known to in-
duce cortactin/CD2AP complexes (33).
Protein-protein interactions are easily detected using bio-
chemical approaches, but verifying their existence in cells remains
a significant challenge. While two-color immunofluorescence co-
localization studies are often employed to support a specific inter-
action, these studies are limited by the low resolution of light
microscopic imaging and often the very broad cellular expression
patterns of a specific protein. Electron microscopy with immuno-
gold labeling can overcome some of the resolution issues, but this
method is highly cumbersome and the number of proteins labeled
is often highly limited. One utility of superresolution methods like
STORM and PALM (32, 47) is that they can robustly localize thou-
sands of single molecules at nanometer resolution and allow for
rigorous statistical analytic tools to be applied to the problem of
colocalization (48). Using two analytic approaches, a colocaliza-
tion and a cross-correlation analysis, we could easily show that the
colocalization of CP and cortactin at the cell periphery required
the presence of CD2AP, a conclusion that was not apparent by
visual inspection of the images. We believe that the quantitative
analysis of protein interactions using STORM and/or PALM will
be especially powerful to validate protein-protein interactions
that are of low stoichiometry and occur at specific locations in the
cell.
In summary, we have demonstrated that two proteins, CP and
cortactin, previously known to be important for actin assembly
and cell migration, form a complex with CD2AP at the periphery
of the cell. By binding cortactin, CD2AP functions to recruit CP to
the periphery of spreading cells. CD2AP thus plays a critical scaf-
folding role to enhance the ability of CP and cortactin to pro-
mote Arp2/3 complex-mediated actin assembly. Branched ac-
tin filaments are also important in vesicular trafficking and
endocytosis, so these findings provide insight into other possi-
ble roles for CD2AP in the function of normal and diseased
cells and tissues.
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